•  
  •  
  •  
  •  

2025-10-03 21:06:49

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand
  • Avenue Supermarts Limited - Update at the end of Q2 of Financial Year 2025-26

Keywords Selected:  IndoRamaSyntheticsIndia

Stock Report

  • Indo Rama Synthetics India Ltd Q1 FY24 consolidated loss widens to Rs. 55.18 crores
  • Indorama Ventures Yarns Pvt Ltd starts commercial production
  • Ind-Ra revises outlook of Indo Rama Synthetics India Limited's long-term issuer rating
  • Indorama Yarns Pvt Ltd commissions Bottle Grade PET resins manufacturing
  • Indo Rama Synthetics India Ltd Q4FY23 consolidated profit at Rs. 1.62 crore
  • Indo Rama Synthetics India Ltd Q3 FY23 consolidated loss at Rs. 65.93 Crores
  • Indo Rama Synthetics India Ltd Q2 FY2022-23 consolidated profit at Rs. 1.14 crore
  • Indo Rama Synthetics India Ltd Q1 FY2023 consolidated PAT declines QoQ to Rs. 38.61 crores
  • Indo Rama Synthetics India Ltd reports Rs. 107.13 crores consolidated net profit in Q4 FY2022
  • Indo Rama Synthetics India Q3FY22 consolidated PAT soars to Rs. 95.40 crores
  • Indo Rama Synthetics India Ltd Q2FY22 consolidated PAT climbs to Rs. 52.31 crore

Latest Post

  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand
  • Avenue Supermarts Limited - Update at the end of Q2 of Financial Year 2025-26


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024